141 related articles for article (PubMed ID: 34579560)
1. TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.
Chowdhury D; Bansal L; Duggal A; Datta D; Mundra A; Krishnan A; Koul A; Gupta A
Cephalalgia; 2022 Apr; 42(4-5):396-408. PubMed ID: 34579560
[TBL] [Abstract][Full Text] [Related]
2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controlled trial.
Chowdhury D; Mundra A; Datta D; Duggal A; Krishnan A; Koul A
Cephalalgia; 2022 Aug; 42(9):859-871. PubMed ID: 35259978
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.
Silberstein SD; Dodick DW; Lindblad AS; Holroyd K; Harrington M; Mathew NT; Hirtz D;
Neurology; 2012 Mar; 78(13):976-84. PubMed ID: 22377815
[TBL] [Abstract][Full Text] [Related]
6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
7. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
8. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
9. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
10. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
Ashtari F; Shaygannejad V; Akbari M
Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
[TBL] [Abstract][Full Text] [Related]
12. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of tiapride and topiramate in the prophylactic treatment of chronic migraine: a randomised, double-blind, pilot study].
Juica-Avello S; Riquelme-Vergara C; Condeza-Riquelme F; González-Burboa A; Fuentealba-Sandoval M; Klaassen-Pinto G; Pérez-Villalobos C; Vera-Calzaretta A; Contreras-Espinoza L; Werlinger-Estay E; Herrera-Hormazábal C
Rev Neurol; 2022 May; 74(10):325-330. PubMed ID: 35548913
[TBL] [Abstract][Full Text] [Related]
14. Topiramate: new indication. Migraine prevention: best avoided.
Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
[TBL] [Abstract][Full Text] [Related]
15. Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.
Reuter U; Ehrlich M; Gendolla A; Heinze A; Klatt J; Wen S; Hours-Zesiger P; Nickisch J; Sieder C; Hentschke C; Maier-Peuschel M
Cephalalgia; 2022 Feb; 42(2):108-118. PubMed ID: 34743579
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
Mathew NT; Jaffri SF
Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial.
Liu L; Chen Q; Zhao L; Lyu T; Nie L; Miao Q; Liu Y; Zheng L; Fu F; Luo Y; Zeng C; Zhang C; Peng P; Zhang Y; Li B
Cephalalgia; 2024 Jun; 44(6):3331024241261080. PubMed ID: 38860524
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Lewis D; Winner P; Saper J; Ness S; Polverejan E; Wang S; Kurland CL; Nye J; Yuen E; Eerdekens M; Ford L
Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in Migraine Prevention: A 2016 Perspective.
Silberstein SD
Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
[TBL] [Abstract][Full Text] [Related]
20. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
